ABT vs CIIT · P/E 25, rev $44.33B vs rev $9.3M
Abbott Laboratories (ABT) versus Tianci International, Inc. Common Stock (CIIT) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Tianci International, Inc. Common Stock (CIIT) is a integrated freight & logistics company listed on NASDAQ.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported CIIT revenue for 2025-07-31 was $9.3M. Net income was -$2.7M. CIIT currently screens at market cap $2.1M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. CIIT currently screens at market cap $2.1M.
Not investment advice. Open the ABT and CIIT stock pages for the full models.
Not investment advice.